Search research articles
Contact Us
Filters
Showing results (271-280 of 326) with videos related to
Page
of 33
Sort By:
Blood
|
July 2, 2010
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann, Andishe Attarbaschi, Martin Schrappe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009
Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Geriatric Medicine
|
March 13, 2026
Association of pre- and postoperative delirium with functional status at discharge after hip fracture: findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
Maria Cristina Ferrara, Francesca Remelli, Caterina Trevisan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Haematologica
|
May 30, 2013
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
Sabina Chiaretti, Antonella Vitale, Gianni Cazzaniga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2019
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
Rob Pieters, Paola De Lorenzo, Philip Ancliffe, et al.
British Journal of Haematology
|
August 16, 2002
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group
Anna Maria Testi, Ilaria Del Giudice, William Arcese, et al.
Aging Clinical and Experimental Research
|
February 7, 2020
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients
Maria Cristina Ferrara, Anita Andreano, Elena Tassistro, et al.
Blood
|
July 2, 2011
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, et al.
Haematologica
|
October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 326) with videos related to
Sort By:
Page
of 33
Blood
|
July 2, 2010
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann, Andishe Attarbaschi, Martin Schrappe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009
Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Geriatric Medicine
|
March 13, 2026
Association of pre- and postoperative delirium with functional status at discharge after hip fracture: findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
Maria Cristina Ferrara, Francesca Remelli, Caterina Trevisan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Haematologica
|
May 30, 2013
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
Sabina Chiaretti, Antonella Vitale, Gianni Cazzaniga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2019
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
Rob Pieters, Paola De Lorenzo, Philip Ancliffe, et al.
British Journal of Haematology
|
August 16, 2002
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group
Anna Maria Testi, Ilaria Del Giudice, William Arcese, et al.
Aging Clinical and Experimental Research
|
February 7, 2020
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients
Maria Cristina Ferrara, Anita Andreano, Elena Tassistro, et al.
Blood
|
July 2, 2011
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, et al.
Haematologica
|
October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.
Page
of 33